These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. The cystathionine beta-synthase variant c.844_845ins68 protects against CNS demyelination in X-linked adrenoleukodystrophy. Linnebank M; Semmler A; Kleijer WJ; van der Sterre ML; Gärtner J; Fliessbach K; Sokolowski P; Köhler W; Schlegel U; Klockgether T; Wanders RJ; Schmidt S; Wüllner U; Kemp S Hum Mutat; 2006 Oct; 27(10):1063-4. PubMed ID: 16941496 [TBL] [Abstract][Full Text] [Related]
17. [Endocrine disease in adrenoleukodystrophy]. Girard S; Bruckert E; Turpin G Ann Med Interne (Paris); 2001 Feb; 152(1):15-26. PubMed ID: 11240421 [TBL] [Abstract][Full Text] [Related]
18. [Diet therapy in the treatment of neuropediatric disorders]. Chaves-Carballo E Rev Neurol; 2003 Aug 1-15; 37(3):267-74. PubMed ID: 12938059 [TBL] [Abstract][Full Text] [Related]
19. Lovastatin therapy for X-linked adrenoleukodystrophy: clinical and biochemical observations on 12 patients. Pai GS; Khan M; Barbosa E; Key LL; Craver JR; Curé JK; Betros R; Singh I Mol Genet Metab; 2000 Apr; 69(4):312-22. PubMed ID: 10870849 [TBL] [Abstract][Full Text] [Related]
20. Predominance of the adrenomyeloneuropathy phenotype of X-linked adrenoleukodystrophy in The Netherlands: a survey of 30 kindreds. van Geel BM; Assies J; Weverling GJ; Barth PG Neurology; 1994 Dec; 44(12):2343-6. PubMed ID: 7991123 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]